Therapeutics: Solute carrier family 7 member 5 (SLC7A5; LAT1)

Cancer

INDICATION: Cancer

In vitro and mouse studies suggest inhibiting SLC7A5 could

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE